Functional differences between human Cx37 polymorphic hemichannels

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 4, 2009, Pages 499-507

  Derouette, Jean Paul ^a   Desplantez, Thomas ^b   Wong, Cindy W ^a   Roth, Isabelle ^a   Kwak, Brenda R ^a   Weingart, Robert ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Atherosclerosis; Connexin; Cx37; Electrophysiology; Genetic polymorphism; Hemichannel

Indexed keywords

ADENOSINE TRIPHOSPHATE; CONNEXIN 37;

ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL MEMBRANE; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROPHYSIOLOGY; GAP JUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEMBRANE CONDUCTANCE; MEMBRANE CURRENT; MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VOLTAGE CLAMP;

ADENOSINE TRIPHOSPHATE; CELL ADHESION; CONNEXINS; ELECTROPHYSIOLOGICAL PHENOMENA; GAP JUNCTIONS; HELA CELLS; HUMANS; POLYMORPHISM, GENETIC; TRANSFECTION;

MUS;

EID: 61449146936     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.12.018     Document Type: Article

References (45)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005) 1685-1695
2. Libby P. Atherosclerosis: disease biology affecting the coronary vasculature. Am. J. Cardiol. 98 (2006) 3Q-9Q
3. Lusis A.J., Fogelman A.M., and Fonarow G.C. Genetic basis of atherosclerosis: part II: clinical implications. Circulation 110 (2004) 2066-2071
4. Topol E.J. The genetics of heart attack. Heart 92 (2006) 855-861
5. Miller D.T., Ridker P.M., Libby P., and Kwiatkowski D.J. Atherosclerosis: the path from genomics to therapeutics. J. Am. Coll. Cardiol. 49 (2007) 1589-1599
6. Boerma M., Forsberg L., Van Zeijl L., Morgenstern R., De Faire U., Lemne C., Erlinge D., Thulin T., Hong Y., and Cotgreave I.A. A genetic polymorphism in connexin37 as a prognostic marker for atherosclerotic plaque development. J. Intern. Med. 246 (1999) 211-218
7. Yeh H.I., Chou Y., Liu H.F., Chang S.C., and Tsai C.H. Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int. J. Cardiol. 81 (2001) 251-255
8. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., Sone T., Tanaka M., and Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N. Engl. J. Med. 347 (2002) 1916-1923
9. Listi F., Candore G., Lio D., Russo M., Colonna-Romano G., Caruso M., Hoffmann E., and Caruso C. Association between C1019T polymorphism of connexin37 and acute myocardial infarction: study in patients from Sicily. Int. J. Cardiol. 102 (2005) 269-271
10. Wong C.W., Christen T., Pfenniger A., James R.W., and Kwak B.R. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction?. Atherosclerosis 191 (2007) 355-361
11. Sohl G., and Willecke K. Gap junctions and the connexin protein family. Cardiovasc. Res. 62 (2004) 228-232
12. Kwak B.R., Mulhaupt F., Veillard N., Gros D.B., and Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 225-230
13. Wong C.W., Christen T., Roth I., Chadjichristos C.E., Derouette J.P., Foglia B.F., Chanson M., Goodenough D.A., and Kwak B.R. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat. Med. 12 (2006) 950-954
14. Eriksson E.E. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr. Opin. Lipidol. 15 (2004) 553-558
15. Galkina E., and Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2292-2301
16. Laird D.W. Life cycle of connexins in health and disease. Biochem. J. 394 (2006) 527-543
17. Koval M. Pathways and control of connexin oligomerization. Trends Cell Biol. 16 (2006) 159-166
18. Saez J.C., Berthoud V.M., Branes M.C., Martinez A.D., and Beyer E.C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev. 83 (2003) 1359-1400
19. Goodenough D.A., and Paul D.L. Beyond the gap: functions of unpaired connexon channels. Nat. Rev., Mol. Cell Biol. 4 (2003) 285-294
20. Thomas M.A., Huang S., Cokoja A., Riccio O., Staub O., Suter S., and Chanson M. Interaction of connexins with protein partners in the control of channel turnover and gating. Biol. Cell 94 (2002) 445-456
21. Duffy H.S., Delmar M., and Spray D.C. Formation of the gap junction nexus: binding partners for connexins. J. Physiol. (Paris) 96 (2002) 243-249
22. Chanson M., and Kwak B.R. Connexin37: a potential modifier gene of inflammatory disease. J. Mol. Med. 85 (2007) 787-795
23. Kwak B.R., Pepper M.S., Gros D.B., and Meda P. Inhibition of endothelial wound repair by dominant negative connexin inhibitors. Mol. Biol. Cell. 12 (2001) 831-845
24. Bader P., and Weingart R. Pitfalls when examining gap junction hemichannels: interference from volume-regulated anion channels. Pflügers Arch. 452 (2006) 396-406
25. Bader P., and Weingart R. Conductive and kinetic properties of connexin45 hemichannels expressed in transfected HeLa cells. J. Membr. Biol. 199 (2004) 143-154
26. Desplantez T., Halliday D., Dupont E., and Weingart R. Cardiac connexins Cx43 and Cx45: formation of diverse gap junction channels with diverse electrical properties. Pflügers Arch. 448 (2004) 363-375
27. Harris A. Emerging issues of connexin channels: biophysics fills the gap. Q. Rev. Biophys. 34 (2001) 325-472
28. Kwak B.R., Veillard N., Pelli G., Mulhaupt F., James R.W., Chanson M., and Mach F. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 107 (2003) 1033-1039
29. Chadjichristos C.E., Matter C.M., Roth I., Sutter E., Pelli G., Luscher T.F., Chanson M., and Kwak B.R. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 113 (2006) 2835-2843
30. Jiang J.X., Siller-Jackson A.J., and Burra S. Roles of gap junctions and hemichannels in bone cell functions and in signal transmission of mechanical stress. Front. Biosci. 12 (2007) 1450-1462
31. Rodriguez-Sinovas A., Cabestrero A., Lopez D., Torre I., Morente M., Abellan A., Miro E., Ruiz-Meana M., and Garcia-Dorado D. The modulatory effects of connexin 43 on cell death/survival beyond cell coupling. Prog. Biophys. Mol. Biol. 94 (2007) 219-232
32. Pointis G., Fiorini C., Gilleron J., Carette D., and Segretain D. Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis. Curr. Med. Chem. 14 (2007) 2288-2303
33. + influx studies. Am. J. Physiol. 258 (1990) C599-C609
34. Cotrina M.L., Lin J.H.C., Alves-Rodrigues A., Liu S., Li J., Azmi-Ghadimi H., Kang J., Naus C.C.G., and Nedergaard M. Connexins regulate calcium signaling by controlling ATP release. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15735-15740
35. John G.R., Scemes E., Suadicani S.O., Liu J.S., Charles P.C., Lee S.C., Spray D.C., and Brosnan C.F. IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11613-11618
36. Trexler E.B., Bukauskas F.F., Bennett M.V.L., Bargiello T.A., and Verselis V.K. Rapid and direct effects of pH on connexins revealed by the connexin46 hemichannel preparation. J. Gen. Physiol. 113 (1999) 721-742
37. Bukauskas F.F., and Verselis V.K. Gap junction channel gating. Biochim. Biophys. Acta 1662 (2004) 42-60
38. Banach K., and Weingart R. Connexin43 gap junction channels exhibit fast and slow current transitions. Pflügers Arch. 439 (2000) 248-250
39. Trexler E.B., Bennett M.V.L., Bargiello T.A., and Verselis V.K. Voltage gating and permeation in a gap junction hemichannel. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5836-5841
40. Bukauskas F.F., Elfgang C., Willecke K., and Weingart R. Biophysical properties of gap junction channels formed by mouse connexin40 in induced pairs of transfected human HeLa cells. Biophys. J. 68 (1995) 2289-2298
41. Valiunas V., and Weingart R. Electrical properties of gap junction hemichannels identified in transfected HeLa cells. Pflügers Arch. 440 (2000) 366-379
42. Lampe P.D., Cooper C.D., King T.J., and Burt J.M. Analysis of connexin43 phosphorylated at S325, S328 and S330 in normoxic and ischemic heart. J. Cell. Sci. 119 (2006) 3435-3442
43. Puljung M.C., Berthoud V.M., Beyer E.C., and Hanck D.A. Polyvalent cations constitute the voltage gating particle in human connexin37 hemichannels. J. Gen. Physiol. 124 (2004) 587-603
44. Kumari S.S., Varadaraj K., Valiunas V., Ramanan S.V., Christensen E.A., Beyer E.C., and Brink P.R. Functional expression and biophysical properties of polymorphic variants of the human gap junction protein connexin37. Biochem. Biophys. Res. Com. 274 (2000) 216-224
45. Lanfear D.E., Jones P.G., Marsh S., Cresci S., Spertus J.A., and McLeod H.L. Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome. Am. Heart J. 154 (2007) 561-566